Synthesis and inhibitory activity of atorvastatin conjugate with a branched asialoglycoprotein receptor ligand with 3 N-acetyl-d-galactosamine residues

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The novel atorvastatin conjugate was synthesized in a multi-step procedure using branched N -acetylgalactosamine ligand for asialoglycoprotein receptor targeting. The molar solubility of the obtained conjugate was 6.1±0.9 mM, which is almost 60 times higher than that of unmodified atorvastatin. The hydrolysis products of the conjugate demonstrated effective inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.

作者简介

S. Maklakova

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

M. Mazhuga

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

A. Lopukhov

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

K. Gibadullina

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

N. Klyachko

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

A. Majouga

Lomonosov Moscow State University;Dmitry Mendeleev University of Chemical Technology of Russia

Email: maklakovasu@yandex.ru

E. Beloglazkina

Lomonosov Moscow State University

Email: maklakovasu@yandex.ru

参考

  1. Рациональная фармакотерапия сердечно-сосудистых заболеваний. Ред. Е.И. Чазов, Ю.А. Карпов. М.: Литтерра. 2016.
  2. Vardanyan R., Hruby V. Synthesis of Best-seller Drugs. London-San Diego-Cambridge-Oxford: Academic Press. 2016, 286-293.
  3. Bratton L.D., Auerbach B., Choi C., Dillon L., Hanselman J.C., Larsen S.D., Lu G., Olsen K., Pfefferkorn J.A., Robertson A., Sekerke C., Trivedi B.K., Unangst P.C. Bioorg. Med. Chem. 2007, 15, 5576-5589. doi: 10.1016/j.bmc.2007.05.031
  4. Rageh A.H., Atia N.N., Abdel-Rahman H.M. J. Pharm. Biomed. Anal. 2017, 142, 7-14. doi: 10.1016/j.jpba.2017.04.037
  5. Roth B.D., Bocan T.M.A., Blankley C.J., Chucholowski A.W., Creger P.L., Creswell M.W., Ferguson E., Newton R.S., O'Brien P. J. Med. Chem. 1991, 34, 463-466. doi: 10.1021/jm00105a071
  6. Zhang Y., Zhang X., Zeng C., Li B., Zhang C., Li W., Hou X., Dong Y. Bioorg. Med. Chem. 2019, 27, 2187-2191. doi: 10.1016/j.bmc.2019.04.019
  7. D'Souza A.A., Devarajan P.V. J. Control. Rel. 2015, 203, 126-139. doi: 10.1016/j.jconrel.2015.02.022
  8. Wang Q., Huang C., Jiang M., Zhu Y., Wang J., Chen J., Shi J. Spectrochim. Acta A: Mol. Biomol. Spectroscopy. 2016, 156, 155-163. doi: 10.1016/j.saa.2015.12.003
  9. Galiullina L.F., Scheidt H.A., Huster D., Aganov A., Klochkov V. Biochim. Biophys. Acta - Biomembr. 2019, 1861, 584-593. doi: 10.1016/j.bbamem.2018.12.013
  10. Huang X., Leroux J.-C., Castanger B. Bioconjugate Chem. 2017, 28, 283-295. doi: 10.1021/acs.bioconjchem.6b00651
  11. Cardona C.M., Gawley R.E. J. Org. Chem. 2002, 67, 1411-1413. doi: 10.1021/jo0161678
  12. Manoharan M., Rajeev K., Nair J., Maier M. Европ. заявка EP 3156077. 2022.
  13. Vickers S., Duncan C.A., Chen I.W., Rosegay A., Duggan D.E. Drug Metab. Dispos. 1990, 18, 138-145.
  14. Vickers S., Duncan C.A., Vyas K.P., Kari P.H., Arison B., Prakash S.R., Ramjit H.G., Pitzenberger S.M., Stokker G., Duggan D.E. Drug Metab. Dispos. 1990, 18, 476-483.
  15. Petrov R.A., Mefedova S.R., Yamansarov E.Y., Maklakova S.Y., Grishin D.A., Lopatukhina E.V., Burenina O.Y., Lopukhov A.V., Kovalev S.V., Timchenko R.V., Ondar E.E., Ivanenkov Y.A., Evteev S.A., Vaneev A.N., Timoshenko R.V., Klyachko N.L., Erofeev A.S., Gorelkin P.V., Beloglazkina E.K., Majouga A.G. Mol. Pharmaceutics. 2021, 18, 461-468. doi: 10.1021/acs.molpharmaceut.0c00980
  16. Mizoi K., Takahashi M., Haba M., Hosokawa M. Bioorg. Med. Chem. Lett. 2016, 26, 921-923. doi: 10.1016/j.bmcl.2015.12.069

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russian Academy of Sciences, 2023